Neogen | NEOG - Operating Expenses

Stock Price
9.54
Daily Change
0.19 2.03%
Monthly
4.15%
Yearly
84.88%
Q2 Forecast
9.34

Neogen reported $214.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Cerus USD 34.78M 2.98M Dec/2024
Danaher USD 52.95B 47.61B Mar/2026
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Illumina USD 903M 69M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Utah Medical Products USD 6.6M 354K Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025